543616-BOM

Trident Lifeline Ltd.

BSE: 543616

SME

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

378.00-3.5 (-0.92%)

13 Oct, 3:30 PM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

81.1 / 100

Value Score

38.4 / 100

Price Momentum Score

83.0 / 100

QVM Score

85.2 / 100

Key Metrics

Market Cap

455.56

P/E (TTM)

18.00

P/B

4.54

P/S (TTM)

2.76

EV/EBITDA

14.34

CAPE (5Y)

48.55

ROE (TTM)

23.10

ROCE (TTM)

14.47

ROA (TTM)

9.69

Avg 3Y ROE

18.67

Earnings 3Y CAGR

48.98

Sales 3Y CAGR

68.65

Sales 5Y CAGR

68.06

Debt/Equity

0.73

Consensus TP

Strong Buy %

Promoter Holding

62.59

Pledged %

6.93

Stock Analysis

Fundamental analysis overview of Trident Lifeline Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is reasonably valued and PE TTM is at a discount to industry median

PE TTM of 18.0 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -44.05%

What is P/E Ratio?

Median: 32.17

Value 18

-0.8728.04

Strong price momentum

Price Momentum score of 83.0 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

83.0 / 100

High and improving ROE

The company reported strong ROE of 23.1% for 12-month ended 30 Jun 2026 and ROE improved by 307 bps from 1 year ago

What is ROE (FY)?

High and improving operating margin

The company reported strong operating margin of 16.9% for 12-month ended 30 Jun 2026 and operating margin improved by 578 bps from 1 year ago

What is Operating profit margin?

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 70.07% for 12-month ended 30 Jun 2026 and the growth was 59.39 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 10.68

Value 70.07

-99.6111701.8

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 119.98% for 12-month ended 30 Jun 2026 and the growth was 112.53 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.73 as on 30 Jun 2026 and Debt to Equity decreased marginally by 0.11 in the last 1 year

What is Debt to Equity?

Negative

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Company's earnings are of moderate quality

Earnings quality score of 31.6 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

31.6 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Trident Lifeline Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Trident Lifeline Ltd. Shareholding Pattern

Quarterly breakdown of Trident Lifeline Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	69.57	69.85	69.99	70.04	70.04	70.04	67.48	65.51	62.99	62.99	63.04	63.04	63.11	64.11	62.85	62.59
Indian Promoter	69.57	68.80	68.94	68.99	68.99	68.99	66.43	64.45	61.94	61.94	61.99	61.99	62.06	63.10	62.31	62.04
Foreign Promoter	-	1.05	1.05	1.05	1.05	1.05	1.05	1.05	1.05	1.05	1.05	1.05	1.04	1.01	0.55	0.55
Institutions	2.94	4.20	4.39	4.36	4.64	4.64	6.02	6.02	6.09	6.09	6.71	7.60	8.12	7.39	7.51	5.51
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	2.94	4.20	4.39	4.36	4.64	4.64	6.02	6.02	6.09	6.09	6.62	7.21	7.71	7.04	7.24	5.25
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.09	0.39	0.41	0.35	0.27	0.26
Non-Institution	27.49	25.95	25.62	25.60	25.32	25.32	26.50	28.47	30.92	30.92	30.25	29.36	28.78	28.50	29.64	31.90
Bodies Corporate	3.87	8.48	8.94	9.13	8.84	9.16	7.30	7.34	8.21	8.36	8.55	7.93	6.58	6.20	5.48	5.47
Others (incl. Retail) No. of shareholders	23.62 1,373	17.47 380	16.68 369	16.47 367	16.48 414	16.16 455	19.20 480	21.13 479	22.71 480	22.56 492	21.70 502	21.43 519	22.20 526	22.30 549	24.16 579	26.43 680

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Trident Lifeline Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
HARDIK DESAI FAMILY TRUST Promoter Group	June-2026	Market Purchase (Buy) 1st Jun 2026	7.07 %	₹ 248.82	9.00 k	₹ 22.39 lac
AMIT BHUPENDRABHAI HALVAWALA Promoter Group	April-2026	Market Sale (Disposal) 1st Apr 2026	1.14 %	₹ 257.76	34.80 k	₹ 89.70 lac
RINKAL MAYURBHAI GAJERA Promoter	April-2026	Market Sale (Disposal) 1st Apr 2026	3.98 %	₹ 262.24	76.20 k	₹ 2.00 cr
HARDIK DESAI FAMILY TRUST Promoter Group	March-2026	Market Purchase (Acquisition) 31st Mar 2026	7.06 %	₹ 254.98	1.20 k	₹ 3.06 lac
Rupaben Chetan Jariwala Promoter	March-2026	Market Sale (Disposal) 31st Mar 2026	5.53 %	₹ 248.12	39.60 k	₹ 98.26 lac
HARDIK DESAI FAMILY TRUST Promoter Group	March-2026	Market Purchase (Acquisition) 16th Mar 2026	7.03 %	₹ 247.00	4.20 k	₹ 10.37 lac
HARDIK DESAI FAMILY TRUST Promoter Group	February-2026	Market Purchase (Acquisition) 23rd Feb 2026	6.98 %	₹ 260.28	1.20 k	₹ 3.12 lac
Rupaben Chetan Jariwala Promoter	February-2026	Market Sale (Disposal) 23rd Feb 2026	5.78 %	₹ 266.84	27.00 k	₹ 72.05 lac
Rupaben Chetan Jariwala Promoter	February-2026	Market Sale (Disposal) 16th Feb 2026	5.81 %	₹ 273.06	3.60 k	₹ 9.83 lac
Rupaben Chetan Jariwala Promoter	February-2026	Market Sale (Disposal) 16th Feb 2026	5.89 %	₹ 279.00	9.60 k	₹ 26.78 lac

No corporate action data available.

Company Profile

Overview of Trident Lifeline Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Trident Lifeline Limited (TLL) is an India-based medication provider. The Company produces and sells finished doses. Its geographical segment includes India, Ghana, Kenya, Peru, Cameroon, Venezuela, and the Rest of the World. It discovered manufacturing formulations under its own brands alongside a ...

Key personnel

Mrs. Nikita Sharma

Compliance Officer, Company Secretary

Mr. Shravan Harikrishna Patel

Managing Director

Mr. Hardik Jigishkumar DesaiD

Executive Chairman of the Board

Mr. Ashish Anandsingh BafnaD

Chief Financial Officer, Additional Executive Director

Mrs. Rupaben Chetanbhai JariwalaD

Whole-Time Director

Mr. Sachin BhandariD

Additional Non-Executive Independent Director

Ms. Smita Kiran DavdaD

Additional Non-Executive Independent Director

Mrs. Falguni Bhavesh JariwalaD

Additional Non-Executive Independent Women Director

View all

Incorporated on

01 Jan 2014

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

IPO date

10 Oct 2022

Free Float

34,30,200

Website

https://www.tridentlifeline.com/

Phone no.

+912612490224

Address

2001, 2nd Floor, APMC, Krushi Bazar, Begumpura, Falsawadi, Ring Road, SURAT, 395003, India

Frequently Asked Questions

What is the current share price of Trident Lifeline Ltd.?

The current share price of Trident Lifeline Ltd. is ₹ 378.00 as of 13 Oct 2026.

What is the market capitalisation of Trident Lifeline Ltd.?

The market capitalisation of Trident Lifeline Ltd. stands at ₹ 455.56 Cr.

What is the PE ratio of Trident Lifeline Ltd.?

The Price-to-Earnings (PE) ratio of Trident Lifeline Ltd. is 18.00 as of the latest trailing twelve months data.

What is the ROE and ROCE of Trident Lifeline Ltd.?

Trident Lifeline Ltd. has a Return on Equity (ROE) of 23.10% and a Return on Capital Employed (ROCE) of 14.47% as per the latest financial reports.

What is the 52-week high and low of Trident Lifeline Ltd.?

The 52-week high of Trident Lifeline Ltd. is - and the 52-week low is -.

What is the dividend yield of Trident Lifeline Ltd.?

The dividend yield of Trident Lifeline Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Trident Lifeline Ltd.?

Foreign Institutional Investors (FII) hold 5.25%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 26.43% of Trident Lifeline Ltd. shares.

What sector does Trident Lifeline Ltd. belong to?

Trident Lifeline Ltd. operates in the Healthcare sector.

What is the beta of Trident Lifeline Ltd.?

The beta of Trident Lifeline Ltd. is 0.00, indicating its price volatility relative to the broader market. Over the past 1 year, Trident Lifeline Ltd. has delivered an absolute return of 32.29%.

What is the RSI of Trident Lifeline Ltd.?

The 14-day Relative Strength Index (RSI) of Trident Lifeline Ltd. is 59.23, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Trident Lifeline Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Trident Lifeline Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Company Profile

Frequently Asked Questions

Company Profile

Stock Analysis